Hot Stocks: E-commerce slide; PLAN, Y takeover deals; NLSN rejects bid; IMGN drops

In other news, ImmunoGen (IMGN) suffered a massive sell-off after revealing clinical trial data for a potential ovarian cancer drug. Sector In Focus.

Read the full article